{
    "Trade/Device Name(s)": [
        "Chemtrue\u00ae Single/Multi-Panel Drug Screen Cassette and Dip Card Tests"
    ],
    "Submitter Information": "Chemtron Biotech, Inc.",
    "510(k) Number": "K102203",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020771"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DIO",
        "DJC",
        "DNK",
        "LCM",
        "LDJ"
    ],
    "Summary Letter Date": "January 10, 2011",
    "Summary Letter Received Date": "January 10, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Cocaine",
        "Marijuana (THC)",
        "Methamphetamine",
        "Opiates (Morphine)",
        "Phencyclidine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Colloidal gold-based immunoassay"
    ],
    "Methodologies": [
        "Competitive immunoassay",
        "Immunochromatography"
    ],
    "Submission Type(s)": [
        "Cassette",
        "Dip Card",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for Chemtrue\u00ae Single/Multi-Panel Drug Screen Cassette and Dip Card Tests for qualitative detection of six drugs of abuse in human urine.",
    "Indications for Use Summary": "Rapid chromatographic immunoassay for qualitative detection of up to six drugs of abuse (amphetamine, cocaine, marijuana, methamphetamine, opiates, phencyclidine) in human urine, providing a preliminary test result for professional, in vitro diagnostic, and prescription use.",
    "fda_folder": "Toxicology"
}